These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34865079)

  • 1. Prediction of out-of-field recurrence after chemoradiotherapy for cervical cancer using a combination model of clinical parameters and magnetic resonance imaging radiomics: a multi-institutional study of the Japanese Radiation Oncology Study Group.
    Ikushima H; Haga A; Ando K; Kato S; Kaneyasu Y; Uno T; Okonogi N; Yoshida K; Ariga T; Isohashi F; Harima Y; Kanemoto A; Ii N; Wakatsuki M; Ohno T
    J Radiat Res; 2022 Jan; 63(1):98-106. PubMed ID: 34865079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of outcome using pretreatment
    Lucia F; Visvikis D; Desseroit MC; Miranda O; Malhaire JP; Robin P; Pradier O; Hatt M; Schick U
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):768-786. PubMed ID: 29222685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.
    Zhang X; Zhao J; Zhang Q; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
    Cancer Imaging; 2022 Jul; 22(1):35. PubMed ID: 35842679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric magnetic resonance imaging-derived radiomics for the prediction of disease-free survival in early-stage squamous cervical cancer.
    Zhou Y; Gu HL; Zhang XL; Tian ZF; Xu XQ; Tang WW
    Eur Radiol; 2022 Apr; 32(4):2540-2551. PubMed ID: 34642807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics analysis for prediction of lymph node metastasis after neoadjuvant chemotherapy based on pretreatment MRI in patients with locally advanced cervical cancer.
    Liu J; Dong L; Zhang X; Wu Q; Yang Z; Zhang Y; Xu C; Wu Q; Wang M
    Front Oncol; 2024; 14():1376640. PubMed ID: 38779088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-based radiomic signatures for pretreatment prognostication in cervical cancer.
    Wagner-Larsen KS; Hodneland E; Fasmer KE; Lura N; Woie K; Bertelsen BI; Salvesen Ø; Halle MK; Smit N; Krakstad C; Haldorsen IS
    Cancer Med; 2023 Oct; 12(20):20251-20265. PubMed ID: 37840437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomograms Combining Clinical and Imaging Parameters to Predict Recurrence and Disease-free Survival After Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
    Zhang Y; Liu L; Zhang K; Su R; Jia H; Qian L; Dong J
    Acad Radiol; 2023 Mar; 30(3):499-508. PubMed ID: 36050264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI radiomics in overall survival prediction of local advanced cervical cancer patients tread by adjuvant chemotherapy following concurrent chemoradiotherapy or concurrent chemoradiotherapy alone.
    Wei G; Jiang P; Tang Z; Qu A; Deng X; Guo F; Sun H; Zhang Y; Gu L; Zhang S; Mu W; Wang J; Tian J
    Magn Reson Imaging; 2022 Sep; 91():81-90. PubMed ID: 35636572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging features of tumor and lymph node to predict clinical outcome in node-positive cervical cancer: a retrospective analysis.
    Park SH; Hahm MH; Bae BK; Chong GO; Jeong SY; Na S; Jeong S; Kim JC
    Radiat Oncol; 2020 Apr; 15(1):86. PubMed ID: 32312283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
    Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
    BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-derived radiomics analysis improves the noninvasive pretreatment identification of multimodality therapy candidates with early-stage cervical cancer.
    Li Y; Ren J; Yang JJ; Cao Y; Xia C; Lee EYP; Chen B; Guan H; Qi YF; Gao X; Tang W; Chen K; Jin ZY; He YL; Xiang Y; Xue HD
    Eur Radiol; 2022 Jun; 32(6):3985-3995. PubMed ID: 35018480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An MRI-based radiomics signature and clinical characteristics for survival prediction in early-stage cervical cancer.
    Zheng RR; Cai MT; Lan L; Huang XW; Yang YJ; Powell M; Lin F
    Br J Radiol; 2022 Jan; 95(1129):20210838. PubMed ID: 34797703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
    Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
    Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images.
    Cusumano D; Russo L; Gui B; Autorino R; Boldrini L; D'Erme L; Persiani S; Catucci F; Broggi S; Panza G; Nardangeli A; Campitelli M; Ferrandina G; Macchia G; Fiorino C; Valentini V; Scambia G; Manfredi R; Gambacorta MA
    Radiother Oncol; 2022 Sep; 174():30-36. PubMed ID: 35811004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IVIM-DWI and MRI-based radiomics in cervical cancer: Prediction of concurrent chemoradiotherapy sensitivity in combination with clinical prognostic factors.
    Zhang Y; Zhang K; Jia H; Xia B; Zang C; Liu Y; Qian L; Dong J
    Magn Reson Imaging; 2022 Sep; 91():37-44. PubMed ID: 35568271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy.
    Zhang Q; Guo J; Ouyang H; Chen S; Zhao X; Yu X
    Eur Radiol; 2022 Apr; 32(4):2529-2539. PubMed ID: 34647177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative prediction of cervical cancer survival using a high-resolution MRI-based radiomics nomogram.
    Li J; Zhou H; Lu X; Wang Y; Pang H; Cesar D; Liu A; Zhou P
    BMC Med Imaging; 2023 Oct; 23(1):153. PubMed ID: 37821840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-based radiomics for pretreatment prediction of response to concurrent chemoradiotherapy in locally advanced cervical squamous cell cancer.
    Zhang X; Zhang Q; Chen Y; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
    Abdom Radiol (NY); 2023 Jan; 48(1):367-376. PubMed ID: 36222869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-based radiomics features for the non-invasive prediction of FIGO stage in cervical carcinoma: A multi-center study.
    Liu Y; Dong TF; Li PJ; Chen LB; Song T
    Magn Reson Imaging; 2024 Jul; 110():170-175. PubMed ID: 38035947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal MRI-based deep-radiomics model predicts response in cervical cancer treated with neoadjuvant chemoradiotherapy.
    Cai Z; Li S; Xiong Z; Lin J; Sun Y
    Sci Rep; 2024 Aug; 14(1):19090. PubMed ID: 39154103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.